Ultimate magazine theme for WordPress.

Just-released report names Cannabis Stock of the Year for 2019! Their last pick has seen a +1,200% return since he released it!

This stock has all of the makings of the next great cannabis stock – early-mover advantage, international exposure and influential partnerships, plus it has a product that is unlike anything else on the market…

You will also receive a free, weekly newsletter to stay on top of the latest industry trends, read analysis on promising cannabis stocks, and more. Click here to receive your Free Report immediately!

BTC
$9,266.81
+0.79%
ETH
$237.60
+1.8%
LTC
$43.63
+2.83%
DASH
$69.70
+1.95%
XMR
$64.25
+0.2%
NXT
$0.01
0%
ETC
$6.04
+4.85%
DOGE
$0.00
+18.14%
ZEC
$54.30
+2.14%
BTS
$0.02
0%
DGB
$0.02
+3.18%
XRP
$0.19
+1.87%
BTCD
$23.28
PPC
$0.27
+5.47%
CRAIG
$0.00
XBS
$0.02
0%
XPY
$0.05
0%
PRC
$0.01
0%
YBC
$25.95
0%
DANK
$0.00

Stocks to Watch: Advanced Emissions Solutions, Inc. (NASDAQ:ADES), Navidea Biopharmaceuticals Inc (NYSEMKT:NAVB)

112

Just-released report names Cannabis Stock of the Year for 2019! Their last pick has seen a +1,200% return since he released it!

This stock has all of the makings of the next great cannabis stock – early-mover advantage, international exposure and influential partnerships, plus it has a product that is unlike anything else on the market…

You will also receive a free, weekly newsletter to stay on top of the latest industry trends, read analysis on promising cannabis stocks, and more. Click here to receive your Free Report immediately!

Advanced Emissions SolutionsAdvanced Emissions Solutions, Inc. (NASDAQ:ADES) update; CCS JV finalizes contract with new Refined Coal investor; Leased and sold RC facilities expected to generate more than $100 million in annual revenues to CCS. Advanced Emissions Solutions, Inc. (NASDAQ:ADES) announced Clean Coal Solutions, LLC, a joint venture among its subsidiary ADA-ES, an affiliate of NexGen Resources Corporation, and an affiliate of The Goldman Sachs Group, Inc., has transferred the membership interests of a special purpose entity holding a Refined Coal facility in exchange for fixed and variable payments that provide to CCS similar economics to those of its other leased and sold RC facilities in full-time operation. The limited liability company is 49.9% owned by a new RC investor with certain CCS affiliates, including an affiliate of the co, holding the remaining equity.

Advanced Emissions Solutions, Inc. (NASDAQ:ADES) shares fell -0.85% to $55.08 in current session.

Navidea Biopharmaceuticals Inc (NYSEMKT:NAVB) announces priority review for the sNDA to expand lymphoseek labeling for sentinel lymph node detection in patients with head and neck cancer. Navidea Biopharmaceuticals Inc (NYSEMKT:NAVB) has announced that the U.S. Food and Drug Administration (:FDA) has accepted the Supplemental New Drug Application (sNDA) and granted a Priority Review for the expanded use of Lymphoseek (technetium 99m tilmanocept) Injection indicated for sentinel lymph node (:SLN) detection in patients with head and neck cancer. Under the Prescription Drug User Fee Act (:PDUFA), the FDA has set a target review date for the Lymphoseek sNDA of June 16, 2014.

The FDA grants priority review status to drug applications that may offer a significant improvement in treatment over existing options. Lymphoseek is currently approved for use in lymphatic mapping procedures performed to aid in the diagnostic evaluation of lymph nodes draining a primary tumor in patients with breast cancer and melanoma.

Navidea Biopharmaceuticals Inc (NYSEMKT:NAVB) share fell -0.52% to $1.93 in current session.

Comments